Dopa for Parkinsonism.
D000380:Agranulocytosis / Q000139:chemically induced; D003365:Costs and Cost Analysis; D004295:Dihydroxyphenylalanine / Q000009:adverse effects / Q000627:therapeutic use*; D006417:Hematuria / Q000139:chemically induced; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*
D004295:Dihydroxyphenylalanine